Authors: Schadlich, PK Brecht, JG Brunetti, M Pagano, E Rangoonwala, B Huppertz, E

Citation: Pk. Schadlich et al., Cost effectiveness of ramipril in patients with non-diabetic nephropathy and hypertension - Economic evaluation of Ramipril Efficacy In Nephropathy (REIN) study for Germany from the perspective of statutory health insurance, PHARMACOECO, 19(5), 2001, pp. 497-512

Authors: Schadlich, PK Brecht, JG

Citation: Pk. Schadlich et Jg. Brecht, Economic evaluation of specific immunotherapy versus symptomatic treatmentof allergic rhinitis in Germany, PHARMACOECO, 17(1), 2000, pp. 37-52

Authors: Schadlich, PK Brecht, JG

Citation: Pk. Schadlich et Jg. Brecht, The cost effectiveness of acamprosate in the treatment of alcoholism in Germany: economic evaluation of the prevention of relapse with acamprosate inthe management of alcoholism (PRAMA) study (vol 13, pg 710, 1998), PHARMACOECO, 17(1), 2000, pp. 69-69

Authors: Brecht, JG Strobele, S Schadlich, PK

Citation: Jg. Brecht et al., Senile dementia: The cost of illness in Germany, PERFUSION, 13(7), 2000, pp. 296

Authors: Brecht, JG Huppertz, E Schadlich, PK Laux, R

Citation: Jg. Brecht et al., Cost-effectiveness analysis of the use of pentoxifylline in peripheral occlusive arterial disease - a model calculation, PERFUSION, 13(5), 2000, pp. 217

Authors: Schadlich, PK Huppertz, E Brecht, JG

Citation: Pk. Schadlich et al., Cost-effectiveness analysis of ramipril in heart failure after myocardial infarction - Economic evaluation of the Acute Infarction Ramipril Efficacy (AIRE) Study for Germany from the Perspective of Statutory Health Insurance, PHARMACOECO, 14(6), 1998, pp. 653-669